Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Erythroblastic, Acute × DNA Methylation × Clear all

Sponsor

Conditions

Central Nervous System Neoplasms 2 Thrombocytopenia 1 Squamous Intraepithelial Lesions 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Oligodendroglioma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Gliosarcoma 1 Glioblastoma 1 Burkitt Lymphoma 1 Astrocytoma 1 Anus Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 Anemia, Refractory 1

Interventions

Cytarabine 21 fludarabine phosphate 9 Mitoxantrone 8 Busulfan 7 Idarubicin 6 Daunorubicin 6 Whole-Body Irradiation 5 Peripheral Blood Stem Cell Transplantation 5 Methotrexate 5 Gemtuzumab 5 Etoposide 5 alvocidib 4 Vorinostat 4 Filgrastim 4 Cyclosporine 4 Cyclophosphamide 4 Clofarabine 4 Azacitidine 4 Antilymphocyte Serum 4 tipifarnib 3 Tacrolimus 3 Mycophenolic Acid 3 Flow Cytometry 3 Decitabine 3 Bortezomib 3 fludarabine 2 aldesleukin 2 Pravastatin 2 Observation 2 In Situ Hybridization, Fluorescence 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡